Literature DB >> 28011648

Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.

Wenyu Fu1, Wenhuo Hu2, Lei Shi1, Jyoti Joshi Mundra1, GuoZhi Xiao3,4, Michael L Dustin5,6, Chuan-Ju Liu7,8.   

Abstract

Progranulin (PGRN) restrains inflammation and is therapeutic against inflammatory arthritis; however, the underlying immunological mechanism remains unknown. In this study, we demonstrated that anti-inflammatory cytokine IL-10 was a critical mediator for PGRN-mediated anti-inflammation in collagen-induced arthritis by using PGRN and IL-10 genetically modified mouse models. IL-10 green fluorescent protein reporter mice revealed that regulatory T (Treg) cells were the predominant source of IL-10 in response to PGRN. In addition, PGRN-mediated expansion and activation of Treg cells, as well as IL-10 production, depends on JNK signaling, but not on known PGRN-activated ERK and PI3K pathways. Furthermore, microarray and chromatin immunoprecipitation sequencing screens led to the discovery of forkhead box protein O4 and signal transducer and activator of transcription 3 as the transcription factors required for PGRN induction of IL-10 in Treg cells. These findings define a previously unrecognized signaling pathway that underlies IL-10 production by PGRN in Treg cells and present new insights into the mechanisms by which PGRN resolves inflammation in inflammatory conditions and autoimmune diseases, particularly inflammatory arthritis.-Fu, W., Hu, W., Shi, L., Mundra, J. J. Xiao, G., Dustin, M. L., Liu, C. Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis. © FASEB.

Entities:  

Keywords:  JNK; TNFR2; Treg

Mesh:

Substances:

Year:  2016        PMID: 28011648      PMCID: PMC5349791          DOI: 10.1096/fj.201601134R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis.

Authors:  Jian Q Feng; Feng-Jin Guo; Bai-Chun Jiang; Yan Zhang; Sally Frenkel; Da-Wei Wang; Wei Tang; Yixia Xie; Chuan-Ju Liu
Journal:  FASEB J       Date:  2010-02-02       Impact factor: 5.191

3.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

Review 4.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Progranulin Controls Sepsis via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.

Authors:  Wenjun Yan; Aihao Ding; Ha-Jeong Kim; Hua Zheng; Fang Wei; Xiaojing Ma
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

7.  Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival.

Authors:  Zhiheng He; Amin Ismail; Leonid Kriazhev; Gulzhakhan Sadvakassova; Andrew Bateman
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

Review 8.  Update on cytokines in rheumatoid arthritis.

Authors:  Fionula Brennan; Jonathan Beech
Journal:  Curr Opin Rheumatol       Date:  2007-05       Impact factor: 5.006

9.  CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.

Authors:  Xuefei Zhu; Peizeng Yang; Hongyan Zhou; Bing Li; Xiangkun Huang; Qianli Meng; Li Wang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-31       Impact factor: 3.117

10.  Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.

Authors:  Jenny L McGovern; Dao X Nguyen; Clare A Notley; Claudia Mauri; David A Isenberg; Michael R Ehrenstein
Journal:  Arthritis Rheum       Date:  2012-10
View more
  17 in total

Review 1.  Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases.

Authors:  Yazhou Cui; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2019-01-30       Impact factor: 7.638

2.  Monitoring Atsttrin-Mediated Inhibition of TNFα/NF-κβ Activation Through In Vivo Bioluminescence Imaging.

Authors:  Aubryanna Hettinghouse; Wenyu Fu; Chuan-Ju Liu
Journal:  Methods Mol Biol       Date:  2021

3.  Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.

Authors:  Yuehong Chen; Jinlong Jian; Aubryanna Hettinghouse; Xueheng Zhao; Kenneth D R Setchell; Ying Sun; Chuan-Ju Liu
Journal:  J Mol Med (Berl)       Date:  2018-10-20       Impact factor: 4.599

Review 4.  Molecular regulations and therapeutic targets of Gaucher disease.

Authors:  Yuehong Chen; Neetu Sud; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2018-04-11       Impact factor: 7.638

5.  Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL-10 and IL-17 Through TNF Pathways.

Authors:  Shaoyi Wang; Jianlu Wei; Yuchen Fan; Hong Ding; Huichao Tian; Xiaocong Zhou; Lei Cheng
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

6.  Prognostic Significance of Serum Interleukins and Soluble ST2 in Traditional Chinese Medicine (TCM) Syndrome-Differentiated Rheumatoid Arthritis.

Authors:  Yu Wang; Zhe Chen; Ying Huang; Liu Yafei; Shenghao Tu
Journal:  Med Sci Monit       Date:  2018-05-25

7.  TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.

Authors:  Wenyu Fu; Wenhuo Hu; Young-Su Yi; Aubryanna Hettinghouse; Guodong Sun; Yufei Bi; Wenjun He; Lei Zhang; Guanmin Gao; Jody Liu; Kazuhito Toyo-Oka; Guozhi Xiao; David B Solit; Png Loke; Chuan-Ju Liu
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 14.808

8.  14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritis.

Authors:  Wenyu Fu; Aubryanna Hettinghouse; Yujianan Chen; Wenhuo Hu; Xiang Ding; Meng Chen; Yuanjing Ding; Jyoti Mundra; Wenhao Song; Ronghan Liu; Young-Su Yi; Mukundan Attur; Jonathan Samuels; Eric Strauss; Philipp Leucht; Ran Schwarzkopf; Chuan-Ju Liu
Journal:  Ann Rheum Dis       Date:  2021-07-05       Impact factor: 19.103

9.  Serum- and Glucocorticoid-Inducible Kinase 1 Promotes Alternative Macrophage Polarization and Restrains Inflammation through FoxO1 and STAT3 Signaling.

Authors:  Junling Ren; Xiao Han; Hannah Lohner; Ruqiang Liang; Shuang Liang; Huizhi Wang
Journal:  J Immunol       Date:  2021-06-23       Impact factor: 5.426

10.  Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.

Authors:  Jinlong Jian; Yuehong Chen; Rossella Liberti; Wenyu Fu; Wenhuo Hu; Rachel Saunders-Pullman; Gregory M Pastores; Ying Chen; Ying Sun; Gregory A Grabowski; Chuan-Ju Liu
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.